Boni Elewski, MD
Enriched profileJames E. Elder, MD Endowed Professor for Graduate Medical Education and Chair, Department of Dermatology · University of Alabama at Birmingham
Boni Elewski is James E. Elder, MD Endowed Professor for Graduate Medical Education and Chair, Department of Dermatology at University of Alabama at Birmingham. OpenAlex indexes 414 publications with 18,075 citations (h-index 63); ClinicalTrials.gov lists 12 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Boni Elewski is James E. Elder, MD Endowed Professor for Graduate Medical Education and Chair, Department of Dermatology at University of Alabama at Birmingham, Department of Dermatology. The public record shows 414 publications with 18,075 citations (h-index 63), centered on Nail Diseases and Treatments, Psoriasis: Treatment and Pathogenesis, Fungal Infections and Studies. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 19 companies.
- Most recent indexed publication: 2026 · American journal of clinical dermatology
- Top research focus: Nail Diseases and Treatments
- 12 registered trials on ClinicalTrials.gov
- Open Payments reporting from 19 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 209.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)
Sponsor: University of Alabama at Birmingham
- A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis
Sponsor: University of Alabama at Birmingham
- Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis
Sponsor: University of Alabama at Birmingham
Industry payments
Updated 14 Oct 2026
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20255 payments$12,537openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20255 payments
- Novartis Pharmaceuticals CorporationProgram year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
22.8%Tetracycline-class Drug10%Doxycycline Monohydrate56%Doxycycline Hyclate44%Part D<11 patientsAzole Antifungal8.4%Ketoconazole100%Part D≥22 patients+ 1 more class in this area
Dermatology
21.6%Interleukin-4 Receptor alpha Antagonist15.8%Dupixent Pen100%Part D≥24 patientsCorticosteroid5.8%Triamcinolone Acetonide100%Part D≥17 patientsCardiovascular
17.7%Arteriolar Vasodilator12.1%Minoxidil100%Part D≥25 patientsCorticosteroid3.3%Fluocinonide100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Trichophyton indotineae: Rise, Diagnosis, Treatment, and Future Directions.
American journal of clinical dermatology
Review2026 - Correction: Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.
Dermatology and therapy
Erratum2025 - Management of Chronic Generalized Pustular Psoriasis: A Review and Expert Opinion.
Journal of psoriasis and psoriatic arthritis
Review2025 - Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions.
Dermatology and therapy
Article2025
Most-cited works
by citation count (OpenAlex)- 01Secukinumab in Plaque Psoriasis — Results of Two Phase 3 TrialsArticle1,979 citations2014
- 02Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologicsArticle945 citations2019
- 03Onychomycosis: Pathogenesis, Diagnosis, and ManagementArticle583 citations1998
- 04The prevalence of acne in adults 20 years and olderArticle567 citations2007
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/boni-elewski-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/boni-elewski-96a81031b
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Boni-E-Elewski-2060564310
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗ - ResearchGate
researchgate.net/scientific-contributions/Boni-Elewski-2139251985
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/p/CFhvEhfh9G_
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Instagram
instagram.com/uabheersink/p/DIRg5W4vARt
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- Board certified
American Board of Dermatology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Editor-in-Chief
SKIN The Journal of Cutaneous Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →skin.dermsquared.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermatologyhalloffame.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providerdirectory.uabmedicine.org ↗
- Inductee
Dermatology Hall of Fame
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermatologyhalloffame.org ↗
Media & interviews
press, podcasts and appearances- Featured profile
"Pioneers in Dermatology and Venereology: An interview with Professor Boni E. Elewski", Journal of the European Academy of Dermatology and Venereology
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onlinelibrary.wiley.com ↗ - Guest on AAD 'Dialogues in Dermatology' podcast
episode on adalimumab for nail psoriasis (phase 3 trial results)
- Video interview
"Boni Elewski, MD: Safety and Efficacy of New Psoriasis Therapies", HCPLive
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗ - Video interview
"Boni Elewski, MD: The Future of Psoriasis Therapy", HCPLive
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Bruce Korf, MD
University of Alabama at Birmingham
Luciano Costa, MD, PhD
University of Alabama at Birmingham
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania